OUR SOLUTION

The Future is EpiSmart

The culmination of 10 years of ophthalmology practice and research

EpiSmart™

Epion has developed a drug, drug delivery devices, and a UVA light device that fully optimize cross-linking and allow for the minimally-invasive treatment for corneal ectasias, including keratoconus.

Unlike current treatments for keratoconus, EpiSmart is designed to be implemented upon initial diagnosis and can prevent disease progression. Epion’s elegant approach elevates the current standard of care for keratoconus by enabling the treatment of both eyes simultaneously and eliminating the need for further deterioration.*

EpiPrep™

  • EpiPrep disposable wand enhances epithelial permeability without disruption

  • EpiPrep disposable loading sponge maintains drug concentration during stromal loading

RiboStat™

  • High concentration of riboflavin drives diffusion into stroma

  • Ideal tonicity and pH for penetration through intact epithelium

  • Sodium iodide removes peroxide, protects cornea and riboflavin, and catalyzes the most favorable reactions for efficient cross-linking

UVA Device

  • High concentration of riboflavin drives diffusion into stroma

  • Ideal tonicity and pH for penetration through intact epithelium

  • Sodium iodide removes peroxide, protects cornea and riboflavin, and catalyzes the most favorable reactions for efficient cross-linking

* EpiSmart is an investigational drug-device combination product. EpiSmart and its components (Epiprep, Ribostat, and UVA Device) are not yet approved by the Food and Drug administration or by other regulatory bodies.